Diabetes Injection Pens Market 2016 Industry Size Share Trends and Analysis to 2020
Deerfield Beach, FL -- (SBWIRE) -- 03/16/2016 -- Diabetes is a metabolic disease that hampers the ability to generate adequate amounts of insulin naturally due to which blood sugar level increases. Diabetes is generally identified after the age of 45 years. Antidiabetic's drugs like insulin are generally given by injection called diabetes injection pens. The accurate amount of insulin is transmitted using this pen. Diabetes injection pens market have made the process less painful and invasive. It is very beneficial for patients who are old or visually impaired. Increasing global prevalence of diabetes is expected to drive the diabetes injection pens market over the forecast period. Some issues like improper amount of insulin and difficulties faced by aged patients are overcome by diabetes injection pens; this factor attributes to the rising demand of diabetes injection pens over the forecast period. Quality of life is another significant factor expected to provide a growth platform to this industry.
Access sample report visit at http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=52727
The report provides a comprehensive view on the diabetes injection pens; we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter's Five Forces model for the diabetes injection pens market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness. The market size and forecasts in terms of revenue (USD million) for the period 2015 to 2020, considering 2014 as the base year, have been provided for this segment of the report.
The report segments the diabetes injection pens market on the basis of type of devices, application and geography. Diabetic pens and pen needle are two major types of device segments analyzed in this study. On the basis of application diabetes injection pens are segmented into reusable insulin pen, and disposable insulin pen. Disposable pens are more convenient as compare to reusable pens. However, cost associated with disposable pen is expected to be major restraint of this market. Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, further bifurcation of region on the country level, which include U.S., Germany, UK, France, China, Japan and India. The branded diabetes pen available in U.S. like SymlinPen 60 & 120, Apidra SoloStar, Byetta, Humalog KwikPen, HumaPen LUXURA HD, Victoza, Humulin Pen, Lantus Solostar, Levemir FlexPen etc. is expected to show lucrative growth in U.S. over the forecast period. Due to which North America dominated the overall industry in terms of revenue in 2014. The key players of the diabetes injection pens market include Eli Lilly and Company, Novo Nordisk, Medtronic, Sanofi S.A., Becton Dickson and Company, and F. Hoffman-La Roche AG.
Inquiry for buying report visit at http://www.syndicatemarketresearch.com/market-analysis/diabetes-injection-pens-market.html#inquiry-for-buying
The report segments the global diabetes injection pens market into:
Global Diabetes Injection Pens Market: Type of Device Segment Analysis
Global Diabetes Injection Pens Market: Application Segment Analysis
Reusable insulin pens
Disposable insulin pens
Global Diabetes Injection Pens Market: Regional Segment Analysis
Middle East & Africa
Read More @ http://www.syndicatemarketresearch.com/market-analysis/diabetes-injection-pens-market.html
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
Toll Free: +1-855-465-4651 (USA-CANADA)